RWINX
Price
$14.83
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VGTSX
Price
$20.49
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

RWINX vs VGTSX

Header iconRWINX vs VGTSX Comparison
Open Charts RWINX vs VGTSXBanner chart's image
Redwood AlphaFactor Tactical Intl N
Price$14.83
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$20.49
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RWINX vs VGTSX Comparison Chart
Loading...
VS
RWINX vs. VGTSX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWINX is a Hold and VGTSX is a Buy.

FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 453B vs. RWINX (202M). RWINX pays higher dividends than VGTSX: RWINX (6.47) vs VGTSX (3.20). RWINX was incepted earlier than VGTSX: RWINX (7 years) vs VGTSX (28 years). RWINX is a more actively managed with annual turnover of: 373.00 vs. VGTSX (4.00). VGTSX has a lower initial minimum investment than RWINX: VGTSX (0) vs RWINX (10000). VGTSX annual gain was more profitable for investors over the last year : 14.27 vs. RWINX (6.95). RWINX return over 5 years is better than : 30.49 vs. VGTSX (24.04).
RWINXVGTSXRWINX / VGTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years28 years-
Gain YTD4.3738.16054%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets202M453B0%
Annual Yield % from dividends6.473.20202%
Returns for 1 year6.9514.2749%
Returns for 3 years0.88-1.46-60%
Returns for 5 years30.4924.04127%
Returns for 10 yearsN/A28.69-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZNTL4.160.06
+1.46%
Zentalis Pharmaceuticals
ACT36.640.30
+0.83%
Enact Holdings
O62.19-0.30
-0.48%
Realty Income Corp
MRVI9.16-0.08
-0.87%
Maravai LifeSciences Holdings
GANX1.48-0.01
-1.00%
Gain Therapeutics